Doctor profile · Federal record
Dr. Leslie Burnside, PA-C
Physician Assistant · Physician Assistant · Chubbuck, ID
- NPI 1760451454
- Accepts Medicare
- 22 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
147 W Chubbuck RD
Chubbuck, ID 832022314
(208) 238-7546
fax (208) 237-9643
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- July 22, 2014
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Idaho #PA518 · Alabama #PA-645
- Medicaid
- ID #807303300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760451454. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
22,405
Distinct HCPCS
10
Medicare allowed
$194,770
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 19,000 | 75 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,183 | 194 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 745 | 427 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 300 | 240 | $40 | |
11102 |
Biopsy of related skin growth, first growth | 198 | 172 | $68 | |
17110 |
Destruction of skin growth, 1-14 growths | 160 | 141 | $85 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 136 | 29 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 114 | 114 | $88 | |
96900 |
Application of ultraviolet light to skin | 110 | 11 | $19 | |
96574 |
Application of light with debridement to destroy precancer skin growth | 105 | 76 | $217 |
In context: peer comparison
Among 3 peers in Chubbuck Physician Assistant, average services per provider: 673. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$807
Transactions
57
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 11 | $213.17 | |
| Novartis Pharmaceuticals Corporation | 26 | $198.41 | |
| Regeneron Healthcare Solutions, INC. | 4 | $91.41 | |
| Leo Pharma INC. | 3 | $74.24 | |
| Dermavant Sciences, INC. | 2 | $39.27 | |
| Arcutis Biotherapeutics, INC. | 2 | $34.62 | |
| Lilly USA, LLC | 2 | $33.62 | |
| Biofrontera INC. | 1 | $25.40 | |
| Ucb, INC. | 1 | $17.15 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $17.03 | |
| Janssen Biotech, INC. | 1 | $16.43 | |
| Fresenius Kabi USA, LLC | 1 | $16.33 | |
| Galderma Laboratories, L.P. | 1 | $15.32 | |
| Genzyme Corporation | 1 | $14.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
980
Patients
571
Total drug cost
$492,783
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 140 | 121 | $1,222 |
| Ketoconazole | Generic | 115 | 57 | $1,364 |
| Clobetasol Propionate | Generic | 112 | 61 | $6,280 |
| Doxycycline Hyclate | Generic | 99 | 54 | $3,434 |
| Mupirocin | Generic | 90 | 70 | $668 |
| Minoxidil | Generic | 67 | 28 | $370 |
| Fluorouracil | Generic | 57 | 52 | $5,754 |
| Finasteride | Generic | 48 | 16 | $354 |
| Nystatin | Generic | 43 | 26 | $603 |
| Imiquimod | Generic | 41 | 22 | $1,944 |
Hospital affiliations
Frequently asked questions
What is Dr. Leslie Burnside's medical specialty?
Dr. Leslie Burnside practices Physician Assistant in Chubbuck, ID.
Where does Dr. Leslie Burnside practice?
Dr. Leslie Burnside practices at 147 W Chubbuck RD, Chubbuck, ID 832022314. Office phone: 2082387546.
What is Dr. Leslie Burnside's NPI?
Dr. Leslie Burnside's National Provider Identifier (NPI) is 1760451454, issued by NPPES.
Does Dr. Leslie Burnside accept Medicare assignment?
Yes. Dr. Leslie Burnside accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Leslie Burnside commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.